TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CELU

Celularity Inc

Healthcare · Biotechnology

1.30$ +3.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement CELU
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
37.3% 29.9% 34.5% 45.2% 109.4% 70.3% 27.6% 24.0%
62.7% 70.1% 65.5% 54.8% -9.4% 29.7% 72.4% 76.0%
165.6% 217.8% 369.1% 414.1% 436.0% 133.8% 32.1% 56.6%
192.1% 214.1% 333.2% 366.4% 222.1% 108.1% 193.1%
0.0% 1,319.1% 1,129.5% 565.9% 133.0% 435.9% 143.1% 307.0%
0.0% -1,249.0% -1,064.0% -511.2% -142.4% -335.9% -70.7% -230.9%
0.0% 17.7% 16.5% 14.9% 17.6% 13.2% 11.6% 25.4%
0.0% -1,267.3% -1,491.3% -469.2% 79.0% -862.0% -106.8% -345.4%
121.4% -265.3% -32.9% 0.1% 0.1% 0.0% 0.0%
0.0% -1,001.9% -1,458.4% -469.3% 79.0% -862.0% -106.8% -345.8%
0.0% -335.6% -1,417.6% -413.0% -772.4% -80.6% -292.5%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?